We failed to find a significant association between circulating IL‐4 (Figure 4A), IL‐10 (Figure 4B), IL‐12 (Figure 4C), IL‐23 (Figure 4D), and MCP‐1 (Figure 4E) levels and glioma risk. Here, IL4 is linked to central nervous system cancer.